The derivatization with the transthyretin binder also did not affect the target-specific cell uptake, which remained high in the PSMA-positive PC-3 PIP tumor cells, while only negligible uptake was seen in PSMA-negative PC-3 flu cells. The gene discussed is TTR; the disease is neoplasm.